HEXO Receivables

HEXO posts a receivables of $25M as of April 2023. That compares with $52M in the prior-year period — down 52.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, HEXO's receivables was $52M. The latest reading is $25M — a 52.6% year-over-year decrease (period ending April 2023). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of HEXO's financial statement story. At $25M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for HEXO's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; HEXO's other metric pages and overview cover the third.

Judging HEXO against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in receivables easier to interpret. Start with $25M here, then scan peer and history charts to see if the gap is persistent.